Shay Shemesh
Vermogen: 33 M $ op 30-06-2026
Vermogen: 33 M $ op 30-06-2026
Shay Shemesh is the founder of Nuvectis Pharma, Inc., founded in 2020, holding the title of EVP, Chief Development & Operations Officer.
Former jobs include Head-Clinical Operations at Keryx Biopharmaceuticals, Inc. and Senior VP-Clinical & Regulatory Affairs at Stemline Therapeutics, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Bar-Ilan University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-04-2026 | 1.793.068 ( 6,76% ) | 33 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVECTIS PHARMA, INC. | Oprichter | 27-07-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
| KERYX BIOPHARMACEUTICALS | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau